Inflammatory cytokines and antigen presenting cell activation

作者: Michael P Murtaugh , Dennis L Foss

DOI: 10.1016/S0165-2427(02)00042-9

关键词:

摘要: Immune responses are stimulated in response to threats against health. In animals, defense infectious agents, particularly rapidly growing viruses and bacteria, requires an immediate limit growth dissemination, then stimulation of a more prolonged, specific immunity prevent re-infection. The process by which animals meet the dual needs danger initiation long-term protection is substantially influenced inflammatory cytokines produced primarily macrophages professional antigen presenting cells (APCs). Inflammatory mobilize immune system increase efficiency as effectors APC function. Here we review evidence for involvement induction mediators activity, with particular emphasis on swine at mucosal surfaces. vast majority infections occur surfaces enteric, respiratory reproductive tracts, protective these sites challenging. Induction small intestine greatly facilitated oral adjuvant, cholera toxin (CT). CT potentiates cytokine costimulatory molecule expression macrophages, stimulates humoral cell-mediated both locally systemically. These observations consistent hypothesis that activation APCs key step antigen-specific immunity, hallmark activated efficacy vaccine adjuvants, context may be determined their ability induce controlled gut-associated lymphoid tissue, characterized various molecules cytokines. Thus, elucidation patterns features will help facilitate rational development efficacious vaccines.

参考文章(97)
Frederick R. Vogel, Michael F. Powell, A Compendium of Vaccine Adjuvants and Excipients Vaccine Design. ,vol. 6, pp. 141- 228 ,(1995) , 10.1007/978-1-4615-1823-5_7
Jessica R. Burdman, Michael F. Powell, Mark J. Newman, Vaccine design : the subunit and adjuvant approach Plenum Press. ,(1995)
Ruslan Medzhitov, Paula Preston-Hurlburt, Charles A. Janeway, A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature. ,vol. 388, pp. 394- 397 ,(1997) , 10.1038/41131
N Y Lycke, L C Agren, L Ekman, B Löwenadler, Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. Journal of Immunology. ,vol. 158, pp. 3936- 3946 ,(1997)
S Sampognaro, L Giannarini, P Romagnani, F Annunziato, P Parronchi, S Romagnani, F Tonelli, E Maggi, A Becchio, C Pupilli, Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. American Journal of Pathology. ,vol. 150, pp. 823- 832 ,(1997)
J Martines, C Bern, I de Zoysa, R I Glass, The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bulletin of The World Health Organization. ,vol. 70, pp. 705- 714 ,(1992)
W V Scheuer, M V Hobbs, W O Weigle, E L Morgan, D E Parks, Modulation of the induction and circumvention of immunological tolerance to human gamma-globulin by interleukin 1. Journal of Immunology. ,vol. 138, pp. 2069- 2074 ,(1987)
D Santoli, S Visonneau, S C Clark, A Cesano, Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. Journal of Immunology. ,vol. 151, pp. 2943- 2957 ,(1993)
P S Linsley, P Marrack, A T Vella, J W Kappler, C B Thompson, B Groth, T Mitchell, J M Green, CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. Journal of Immunology. ,vol. 158, pp. 4714- 4720 ,(1997)